Beleave Kannabis Corp.

publicPublic Group

Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading ...

people3 Members       (0)

Corporate Profile
Group Admins:
  • Thumb 8020 monitor 200200 2
Add Corporate Feed


Beleave Kannabis Corp.

publicPublicGroup

Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high......

people3 Members       (0)

Thumb 8020 monitor 200200 2

8020 Admin

1 day ago

8020 Admin posted a press release Beleave Enters LOI with Dutchman's Gold to Partner on Cannabis Infused Honey Products in BELEAVE KANNABIS CORP.

Toronto, Ontario--(Newsfile Corp. - March 3, 2020) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company"), a licensed producer of cannabis and cannabis-derived products, announces that it has entered into a non-binding Letter of Intent ("LOI") with Dutchman's Gold, on March 2, 2020, to partner on the production and distribution of cannabis-infused natural honey and maple syrup products under the Sticky Icky and Dutchman's Gold brands for the Cannabis 2.0 Canadian market.


"The evolution of Dutchman's Gold and Sticky Icky brand portfolios has been in the works for quite some time, and our team is looking forward to working with them to develop these new product formulations for evolving consumer preferences," says Kevin Keagan, Beleave CEO. "It's been great working with everyone at Shaxon Enterprises, who helped facilitate this partnership, as they've been instrumental in bringing numerous opportunities to launch Cannabis 2.0 products for the Canadian marketplace."



  • Dutchman's Gold will use Beleave's extracts, edibles, and topicals license to sell their manufactured edibles through Beleave's distribution agreements;

  • Beleave will manufacture, package, label, and ship to approved provincial distributors;

  • Dutchman's Gold will provide all of the required honey ingredients for product formulation.


Dutchman's Gold is a Canadian producer of honey products with almost four decades of experience perfecting the craft of delivering unpasteurized, award winning natural honey for consumers. Launched in 1981, the Van Alten family started Dutchman's Gold locally, selling bottled honey off the front porch of the family home and in local farmer's markets. Today, Dutchman's offers dozens of honey and bee products globally from their two facilities in Ontario, Canada and employs dozens from the local community, while ensuring the health and sustainability of Canadian bees and beekeepers.


To complete the transaction, both Beleave and Dutchman's will seek the approval of their respective Board of Directors in the coming weeks. Beleave looks forward to providing further updates to the market as the transaction is finalized and other developments occur.


Private Placement Offering


The Company would also like to announce a non-brokered private placement of up to CAD $500,000 being offered to the public at a 20 Day VWAP. Each unit is comprised of one common share of the Company and one common share purchase warrant of the Company. This entitles the holder to purchase one common share of the Company at an exercise price of CAD $0.05 following a four-month hold and expiring 24 months following the closing date. The net proceeds of the Private Placement will be used by Beleave for general corporate purposes and capital expenditures.


Please contact Don Shaxon at (289) 697-8625 for more information.


About Beleave Inc.


Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives.


Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2020. Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.


Investor Relations Contact:
Kevin Keagan
Chief Executive Officer
Phone: 1 (647) 449 - 7352
Email: kkeagan@beleave.com


Forward-Looking Statements


This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/53099

!
Thumb 8020 monitor 200200 2

8020 Admin

2 days ago

8020 Admin posted a press release Beleave Announces Approval for Sales in Alberta in BELEAVE KANNABIS CORP.

Toronto, Ontario--(Newsfile Corp. - March 2, 2020) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company"), a licensed producer of cannabis and cannabis-derived products, announces that it is now approved for sales in the province of Alberta.


The province, with over 400 licensed stores, has more retail locations than all other provinces combined and reported CAD $255 million in legal cannabis retail store sales in 2019 (as reported by StatsCan), making it the second largest in provincial retail cannabis sales.


"We're very excited for the opportunity to be distributing our cannabis and cannabis-derived products in Alberta," said Kevin Keagan, Beleave CEO. "The province's cannabis market, and extensive network of licensed retail outlets, presents an enormous opportunity for Beleave as we expand our footprint across Canada."


The Company looks forward to updating the market further as first orders and shipments are expected in the coming weeks.


Subscription Agreement Announcement Correction
The Company wishes to correct an error in its press release issued February 26, 2020. The correct number of common shares issued in connection with the Company's financing coordinated through Shaxon Enterprises is 9,342,561, rather than 1,500,000. The Company raised gross proceeds of CAD $270,000. This correction does not change any other amounts or information reported in the February 26, 2020 press release.


About Beleave Inc.
Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives.


Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2020. Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.


Investor Relations Contact:
Kevin Keagan
Chief Executive Officer
Phone: 1 (647) 449 - 7352
Email: kkeagan@beleave.com


Forward-Looking Statements


This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/53043

!
Thumb 8020 monitor 200200 2

8020 Admin

7 days ago

8020 Admin posted a press release Beleave Expands Cannabis 2.0 Product Roll Out to British Columbia with Flyte Classic Vaporizer in BELEAVE KANNABIS CORP.

Toronto, Ontario--(Newsfile Corp. - February 26, 2020) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company"), a licensed producer of cannabis and cannabis-derived products, continues the roll out of its portfolio of adult use cannabis products with Flyte Classic vape pens, recently relaunched into the Canadian market in conjunction with Volero Brands Inc. ("Volero"). The product is now available in the brand's home province, British Columbia, with Manitoba and Saskatchewan product deliveries this week.


A legacy brand acquired by Volero and produced by Beleave, Flyte Classic wickless, low-profile, ceramic core cartridges are sold in 0.5 gram net weight units (kits include slim-form 100mAh batteries). Each cartridge contains 300 mg of THC and is available through provincial cannabis brick-and-mortar and online stores, as well as Licenced Retail Outlets ("LRO") in British Columbia, Manitoba and Saskatchewan.


"We have focused our efforts to be prepared for a successful launch of Cannabis 2.0 products as Canada moves forward with newly allowed product categories," said Kevin Keagan, Beleave CEO. "With this expansion of our Flyte product into Western Canada and British Columbia, we are excited for Canadians to have access to high-quality, safe alternative cannabis products for which the market has been anxiously awaiting."


Launching in BC was a priority for the Flyte brand, recognizing the supporters who had made it a legacy favourite in its home province.


Beleave has been developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for release throughout 2020 as Canadians are increasingly looking for new and safe ways to consume cannabis.


Operational Update


The Company also announced today that it has closed on a Subscription Agreement (the "Agreement") with a private purchaser (the "Purchaser"), totalling CAD $270,000. The transaction was coordinated by Shaxon Enterprises, with whom Beleave entered into an agreement last month to provide consulting and capital raising services for the Company.


Under the terms of the Agreement, the Purchaser has agreed to subscribe to a total of 1,500,000 common shares, at a price per unit based on a 20-day VWAP. Each unit is comprised of one common share of the Company and one common share purchase warrant of the Company. This entitles the holder to purchase one common share of the Company at an exercise price of $0.05 following a four-month hold and expiring 24 months following the closing date.


Beleave anticipates using the proceeds from the transaction to fund its day-to-day operations and expansion activities.


About Beleave Inc.


Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives.


Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2020. Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.


About Volero Brands Inc.


Volero Brands is a privately held, British Columbia-based company engaged in the development of a family of cannabis brands and delivery systems for Canadian and international markets. The Company's flagship brand is Flyte, a suite of popular cannabis distillate products.


The Flyte brand and expertise has been licensed in the state of Nevada for concentrates prepared from distillates of phytocannabinoids and packaged in vaporizer pen cartridges. The Company brings deep technical and brand expertise to extraction, formulation, development and marketing of cannabis distillate-based products.


Investor Relations Contact:
Kevin Keagan
Chief Executive Officer
Phone: 1 (647) 449 - 7352
Email: kkeagan@beleave.com


Forward-Looking Statements


This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52826

!
Thumb 8020 monitor 200200 2

8020 Admin

1 month ago

8020 Admin posted a press release Beleave Announces Consulting Agreement with Shaxon Enterprises in BELEAVE KANNABIS CORP.

Toronto, Ontario--(Newsfile Corp. - January 24, 2020) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has entered into a consulting agreement (the "Agreement") with Shaxon Enterprises Ltd. ("Shaxon" or the "Consultant"), with respect to Shaxon providing consulting services to the Company, effective February 1, 2020.


As part of the agreement, Don Shaxon, Chief Executive Officer of Shaxon Enterprises, will be a special advisor to the Company's Board of Directors and provide advice regarding Beleave's operations, business development, business opportunities, raising capital, management strategies, and corporate communications.


"The legal cannabis industry will forever be changing and evolving. While the industry is still in its infancy, these frequent regulation changes and market fluctuations present new opportunities that weren't previously available," said Shaxon. "With the Canadian rollout of Cannabis 2.0, Beleave has become one of very few licensed producers currently positioned to take full advantage of this budding market."


In addition, Shaxon Enterprises team members, Jason Springett, Corporate Development Manager, and Mike McMillan, Business Development and Strategic Alliance Manager will assist in the growth and development of an innovative future for Beleave.


"I am very excited to be a part of the Beleave team," said McMillan. "I'm equally excited to be able to work with a company that possesses such incredible potential."


About Beleave Inc.


Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives.


Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2020. Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.


Investor Relations Contact:
Kevin Keagan
Chief Executive Officer
Phone: 1 (647) 449 - 7352
Email: kkeagan@beleave.com


Forward-Looking Statements


This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.


"The approval of cannabis vape pens in Canada comes in the midst of news of lung ailments in the U.S. associated with vaping. Many of those who fell ill were vaping contaminated black-market cannabis oil. States typically don't require manufacturers to submit safety data before marketing their products, nor do they conduct random spot checking of cannabis products at production premises to make sure that what manufacturers claim about their products is true.



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/51797

!
Thumb 8020 monitor 200200 2

8020 Admin

3 months ago

8020 Admin posted a press release IIROC Trade Resumption - BE in BELEAVE KANNABIS CORP.





VANCOUVER, Dec. 19, 2019 /CNW/ - Trading resumes in:


Company: Beleave Inc.


CSE Symbol: BE


Resumption (ET): 10:00 AM


IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.


SOURCE Investment Industry Regulatory Organization of Canada (IIROC)


View original content: http://www.newswire.ca/en/releases/archive/December2019/19/c7651.html



For further information about IIROC's trading halt policy, please see Trading Halts & Timely Disclosure (http://www.iiroc.ca/industry/marketmonitoringanalysis/Pages/Trading-Halts-Timely-Disclosure.aspx) at www.iiroc.ca under the Halts & Resumptions tab. Please note that IIROC staff cannot provide any information about a specific halt beyond what is contained in this halt notice. For general information about IIROC, contact IIROC's Complaints & Inquiries team at inquiries@iiroc.ca or 1-877-442-4322 (Option 2). For company-related enquiries, contact the company directly.

!
Thumb 8020 monitor 200200 2

8020 Admin

3 months ago

8020 Admin posted a press release Beleave Receives Purchase Order for Cannabis 2.0 Products and Provides Other Operational Updates in BELEAVE KANNABIS CORP.

Announcing new product line, Compliance Brand, to join Flyte Classic vape pens in Cannabis 2.0 product line, The Company has $2.7 Million in orders for Cannabis 2.0 products, which will ship in early 2020

Toronto, Ontario--(Newsfile Corp. - December 19, 2019) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") is pleased to provide the following updates on its operations.


Compliance Brand Topicals


Beleave is excited to announce the launch of Compliance Brand, a new line of recreational cannabis-infused topical products, and the second initiative from Beleave and Volero Brands Inc.'s ("Volero") joint venture (the "Joint Venture" or "Partnership") after Flyte Classic vape pens. Announced on October 2019, the Partnership was formed to develop, produce, and distribute cannabis extracts, topicals, and edibles for the Canadian adult-use market.


Compliance Brands will launch with three products:



  • THC-Infused Face Serum

    • An exceptionally light oil-based face serum that absorbs almost instantly into skin. This oil blend, high in linoleic acids, will not leave a greasy feeling on your skin. Contains jojoba seed, rosehip and lavender oils with a hemp seed ester and vitamin E.





  • THC-Infused Bath Oil

    • All you need is a gentle stir to mix this product into your bath right away without slicks or residues. Contains hemp seed, birch bark, eucalyptus, marjoram, black pepper and nutmeg oils.





  • THC-Infused Multi-Use Balm

    • This multi-purpose balm was created for every skin. Can be applied to lips, elbows, knees, heels or anywhere else that needs help and hydration. Contains coconut, apricot, hemp seed, jojoba, peppermint, rosemary and lavender oils with vitamin E.




Purchase Orders and Cannabis 2.0 Sales

This week, Beleave received the largest purchase order from a province in the Company’s history. The Company now has $2.7 Million in orders, which will ship in early 2020, for Cannabis 2.0 products.


Additional Employment Positions


Beleave's Human Resources team is seeking applications for seven new employment positions within the Company to bolster its workforce to assist with expanded operations in the coming months. Available positions will be posted publicly as needed.


Lloydminster, Saskatchewan Retail Store Update


As previously announced, the Company has finalized the sale of its retail location in Lloydminster, Saskatchewan and met all the criteria for the transfer of the license to the purchaser. The Company is now awaiting the SLGA's transfer of the license for the transaction to be completed, which it expects in the very near future.


London, Ontario Facility Update


With 250,000 sq ft of greenhouse space and 85 acres of land, the London, Ontario facility has received tremendous interest since it was placed on the market earlier this year. The Company looks forward to providing additional updates once an agreement has been finalized.


ABOUT BELEAVE INC.


Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives.


Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2019. Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.

Investor Relations Contact:
Kevin Keagan
Chief Executive Officer
Phone: 1 (647) 449 - 7352
Email: kkeagan@beleave.com

Forward-Looking Statements


This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.


To view the source version of this press release, please visit https://www.newsfilecorp.com/release/50951

!
Thumb 8020 monitor 200200 2

8020 Admin

3 months ago

8020 Admin posted a press release Beleave Provides Update on Company Leadership in BELEAVE KANNABIS CORP.

Toronto, Ontario--(Newsfile Corp. - December 19, 2019) - Today, Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") announces the appointment of Mr. Kevin Keagan as its Chief Executive Officer, effective immediately, replacing Ms. Jeannette VanderMarel, who has resigned from her position. Ms. VanderMarel will maintain her position on the Company's board.


Mr. Keagan joined Beleave in October 28, 2018 as the Company's Chief Communications Officer. He brought his extensive experience, with over 25 years in capital markets working within the financial services industry, to his oversight of the operation, expansion, and direction of Beleave's communications and capital markets initiatives.


In January 2019, Kevin became Beleave's interim Chief Financial Officer, a role he performed until his appointment as CEO today.


"This has been a demanding year for the cannabis industry, and I appreciate the hard work, innovation, and determination that is required as we move steadfastly into the future," said Keagan. "I look forward to continuing to realize the benefits of our efforts, announcing new products and strategies, and evolving to grow our business in this exciting time. Canadians are increasingly looking for new and safe ways to consume cannabis, and our investments in Cannabis 2.0 products allows us to meet that demand, while maintaining strict protocols and introducing higher-margin, standardized products - strengthening our bottom line."


Beleave also announced that Debora Bielecki has voluntarily resigned from her position on Beleave's Board of Directors, effective immediately.


ABOUT BELEAVE INC.


Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives.


Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2019. Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.

Investor Relations Contact:
Kevin Keagan
Chief Executive Officer
Phone: 1(647)449-7352
Email: kkeagan@beleave.com


Forward-Looking Statements


This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/50948

!
Thumb 8020 monitor 200200 2

8020 Admin

3 months ago

8020 Admin posted a press release IIROC Trading Halt - BE in BELEAVE KANNABIS CORP.





VANCOUVER, Dec. 18, 2019 /CNW/ - The following issues have been halted by IIROC:


Company: Beleave Inc.


CSE Symbol: BE


Reason: At the request of the Company Pending News


Halt Time (ET): 10:32 AM


IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.


SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions


View original content: http://www.newswire.ca/en/releases/archive/December2019/18/c8499.html

For further information about IIROC's trading halt policy, please see Trading Halts & Timely Disclosure (http://www.iiroc.ca/industry/marketmonitoringanalysis/Pages/Trading-Halts-Timely-Disclosure.aspx) at www.iiroc.ca under the Halts & Resumptions tab. Please note that IIROC staff cannot provide any information about a specific halt beyond what is contained in this halt notice. For general information about IIROC, contact IIROC's Complaints & Inquiries team at inquiries@iiroc.ca or 1-877-442-4322 (Option 2). For company-related enquiries, contact the company directly.

!
Thumb 8020 monitor 200200 2

8020 Admin

4 months ago

8020 Admin posted a press release Beleave Announces Joint Venture with Volero Brands to Launch Cannabis 2.0 Products in Canada in BELEAVE KANNABIS CORP.

Toronto, Ontario--(Newsfile Corp. - October 31, 2019) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") and Volero Brands Inc. ("Volero") are pleased to announce that they have entered into a definitive agreement (the "Joint Venture Agreement") to form a joint venture (the "Joint Venture" or "Partnership") to develop, produce, and distribute cannabis extracts, topicals and edibles for the Canadian market.


"Innovation, strong leadership, and the ability to navigate the regulatory landscape are core capabilities required for differentiation and future success in the rapidly evolving Canadian cannabis market," said Jeannette VanderMarel, Beleave CEO. "We are thrilled to be working with Sean and the Volero team as they have an unparalleled depth of knowledge and experience in the cannabis space. Our partnership with Volero will allow us to effectively produce the quality products clients and patients have come to expect from Beleave."


"We're excited to partner with Beleave and bring an entirely new product category to the Canadian market. Our team knows that the best results are delivered when great people come together to collaborate with a common vision. This is exactly the environment we have right now with the team at Beleave," said Sean Trustham, Volero CEO. "This is just the beginning. As we continue to develop and introduce unique products in the coming months, we will keep setting ourselves and our brands apart to ensure that, in the end, we will have fully leveraged this opportunity to establish a leading position in the cannabis extracts markets."


Canadians are increasingly looking for new and safe ways to consume cannabis, and this partnership allows Beleave to meet that need while maintaining strict protocols and introducing standardized products with higher margins. Cannabis 2.0 regulations are in response to a significant and unmet demand in the legal medical cannabis market to provide more flexibility in how cannabis is consumed.


Leveraging Beleave's production capacity, scale, reach, and sales network to drive growth for new products in the Canadian market, the Partnership outlines plans for the roll-out of extracts, topicals and edibles throughout 2020, beginning with Flyte vape pens in December 2019. Launching with six flavours, Flyte pens and refill cartridges are the first of a broader line of cannabinoid-based products Beleave and Volero intend to launch in the future.


"The cannabis concentrate that will be sold in Flyte vapes will meet federal quality regulations as outlined by Health Canada," said Dr. Roger Ferreira, Beleave's Chief Science Officer. "When you extract and concentrate cannabis, you're able to deliver the active ingredient as a more potent formulation. We start with cannabis that is rigorously tested and free from pesticides and heavy metals to ensure a clean and safe end product. We work hard to produce high quality, standardized products to meet the demands of our clients and patients, with safety top of mind."


The first release of Flyte vape pen cartridges will be sold in 0.5 gram net weight units (kits include slim-form 100mAh batteries). Each cartridge will contain 300 mg of THC. Like all Beleave products, Flyte pens will come with publicly available, independent laboratory analysis reports on cannabinoid potency, terpene profiles, as well as pesticide and contaminant screening.


On October 30, Beleave announced it had received an amendment to its processing license from Health Canada to authorize the sale of cannabis extracts, topicals and edible cannabis products to provincially and territorially authorized retailers. The amendment allows Beleave to participate in the newly announced Cannabis 2.0 regulations that went into effect October 17, 2019. Companies must give notice to Health Canada about new products and Beleave has already submitted the required 60-day notification, with sales anticipated to begin this December through Beleave's existing sales and distribution channels.


About Volero Brands


Volero Brands is a privately held, British Columbia-based company engaged in the development of a family of cannabis brands and delivery systems for Canadian and international markets. The Company's flagship brand is Flyte, a suite of top-quality cannabis distillate products. The Flyte brand and expertise has been licensed in the state of Nevada for concentrates prepared from distillates of phytocannabinoids and packaged in vaporizer pen cartridges. The Company brings deep technical and brand expertise to extraction, formulation, development and marketing of cannabis distillate-based products.


About Beleave Inc.


Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives.


Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2019. Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.


Investor Relations Contact:


Kevin Keagan
Interim Chief Financial Officer
Phone: 1 (647) 449 - 7352
Email: kkeagan@beleave.com


Forward-Looking Statements


This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/49299

!

Beleave Kannabis Corp.

publicPublic Group

Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading ...

people3 Members       (0)

Corporate Profile
Group Admins:
  • Thumb 8020 monitor 200200 2
Add Corporate Feed


Beleave Kannabis Corp.

publicPublicGroup

Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high......

people3 Members       (0)

Thumb 8020 monitor 200200 2

8020 Admin

1 day ago

8020 Admin posted a press release Beleave Enters LOI with Dutchman's Gold to Partner on Cannabis Infused Honey Products in BELEAVE KANNABIS CORP.

Toronto, Ontario--(Newsfile Corp. - March 3, 2020) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company"), a licensed producer of cannabis and cannabis-derived products, announces that it has entered into a non-binding Letter of Intent ("LOI") with Dutchman's Gold, on March 2, 2020, to partner on the production and distribution of cannabis-infused natural honey and maple syrup products under the Sticky Icky and Dutchman's Gold brands for the Cannabis 2.0 Canadian market.


"The evolution of Dutchman's Gold and Sticky Icky brand portfolios has been in the works for quite some time, and our team is looking forward to working with them to develop these new product formulations for evolving consumer preferences," says Kevin Keagan, Beleave CEO. "It's been great working with everyone at Shaxon Enterprises, who helped facilitate this partnership, as they've been instrumental in bringing numerous opportunities to launch Cannabis 2.0 products for the Canadian marketplace."



  • Dutchman's Gold will use Beleave's extracts, edibles, and topicals license to sell their manufactured edibles through Beleave's distribution agreements;

  • Beleave will manufacture, package, label, and ship to approved provincial distributors;

  • Dutchman's Gold will provide all of the required honey ingredients for product formulation.


Dutchman's Gold is a Canadian producer of honey products with almost four decades of experience perfecting the craft of delivering unpasteurized, award winning natural honey for consumers. Launched in 1981, the Van Alten family started Dutchman's Gold locally, selling bottled honey off the front porch of the family home and in local farmer's markets. Today, Dutchman's offers dozens of honey and bee products globally from their two facilities in Ontario, Canada and employs dozens from the local community, while ensuring the health and sustainability of Canadian bees and beekeepers.


To complete the transaction, both Beleave and Dutchman's will seek the approval of their respective Board of Directors in the coming weeks. Beleave looks forward to providing further updates to the market as the transaction is finalized and other developments occur.


Private Placement Offering


The Company would also like to announce a non-brokered private placement of up to CAD $500,000 being offered to the public at a 20 Day VWAP. Each unit is comprised of one common share of the Company and one common share purchase warrant of the Company. This entitles the holder to purchase one common share of the Company at an exercise price of CAD $0.05 following a four-month hold and expiring 24 months following the closing date. The net proceeds of the Private Placement will be used by Beleave for general corporate purposes and capital expenditures.


Please contact Don Shaxon at (289) 697-8625 for more information.


About Beleave Inc.


Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives.


Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2020. Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.


Investor Relations Contact:
Kevin Keagan
Chief Executive Officer
Phone: 1 (647) 449 - 7352
Email: kkeagan@beleave.com


Forward-Looking Statements


This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/53099

!
Thumb 8020 monitor 200200 2

8020 Admin

2 days ago

8020 Admin posted a press release Beleave Announces Approval for Sales in Alberta in BELEAVE KANNABIS CORP.

Toronto, Ontario--(Newsfile Corp. - March 2, 2020) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company"), a licensed producer of cannabis and cannabis-derived products, announces that it is now approved for sales in the province of Alberta.


The province, with over 400 licensed stores, has more retail locations than all other provinces combined and reported CAD $255 million in legal cannabis retail store sales in 2019 (as reported by StatsCan), making it the second largest in provincial retail cannabis sales.


"We're very excited for the opportunity to be distributing our cannabis and cannabis-derived products in Alberta," said Kevin Keagan, Beleave CEO. "The province's cannabis market, and extensive network of licensed retail outlets, presents an enormous opportunity for Beleave as we expand our footprint across Canada."


The Company looks forward to updating the market further as first orders and shipments are expected in the coming weeks.


Subscription Agreement Announcement Correction
The Company wishes to correct an error in its press release issued February 26, 2020. The correct number of common shares issued in connection with the Company's financing coordinated through Shaxon Enterprises is 9,342,561, rather than 1,500,000. The Company raised gross proceeds of CAD $270,000. This correction does not change any other amounts or information reported in the February 26, 2020 press release.


About Beleave Inc.
Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives.


Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2020. Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.


Investor Relations Contact:
Kevin Keagan
Chief Executive Officer
Phone: 1 (647) 449 - 7352
Email: kkeagan@beleave.com


Forward-Looking Statements


This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/53043

!
Thumb 8020 monitor 200200 2

8020 Admin

7 days ago

8020 Admin posted a press release Beleave Expands Cannabis 2.0 Product Roll Out to British Columbia with Flyte Classic Vaporizer in BELEAVE KANNABIS CORP.

Toronto, Ontario--(Newsfile Corp. - February 26, 2020) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company"), a licensed producer of cannabis and cannabis-derived products, continues the roll out of its portfolio of adult use cannabis products with Flyte Classic vape pens, recently relaunched into the Canadian market in conjunction with Volero Brands Inc. ("Volero"). The product is now available in the brand's home province, British Columbia, with Manitoba and Saskatchewan product deliveries this week.


A legacy brand acquired by Volero and produced by Beleave, Flyte Classic wickless, low-profile, ceramic core cartridges are sold in 0.5 gram net weight units (kits include slim-form 100mAh batteries). Each cartridge contains 300 mg of THC and is available through provincial cannabis brick-and-mortar and online stores, as well as Licenced Retail Outlets ("LRO") in British Columbia, Manitoba and Saskatchewan.


"We have focused our efforts to be prepared for a successful launch of Cannabis 2.0 products as Canada moves forward with newly allowed product categories," said Kevin Keagan, Beleave CEO. "With this expansion of our Flyte product into Western Canada and British Columbia, we are excited for Canadians to have access to high-quality, safe alternative cannabis products for which the market has been anxiously awaiting."


Launching in BC was a priority for the Flyte brand, recognizing the supporters who had made it a legacy favourite in its home province.


Beleave has been developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for release throughout 2020 as Canadians are increasingly looking for new and safe ways to consume cannabis.


Operational Update


The Company also announced today that it has closed on a Subscription Agreement (the "Agreement") with a private purchaser (the "Purchaser"), totalling CAD $270,000. The transaction was coordinated by Shaxon Enterprises, with whom Beleave entered into an agreement last month to provide consulting and capital raising services for the Company.


Under the terms of the Agreement, the Purchaser has agreed to subscribe to a total of 1,500,000 common shares, at a price per unit based on a 20-day VWAP. Each unit is comprised of one common share of the Company and one common share purchase warrant of the Company. This entitles the holder to purchase one common share of the Company at an exercise price of $0.05 following a four-month hold and expiring 24 months following the closing date.


Beleave anticipates using the proceeds from the transaction to fund its day-to-day operations and expansion activities.


About Beleave Inc.


Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives.


Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2020. Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.


About Volero Brands Inc.


Volero Brands is a privately held, British Columbia-based company engaged in the development of a family of cannabis brands and delivery systems for Canadian and international markets. The Company's flagship brand is Flyte, a suite of popular cannabis distillate products.


The Flyte brand and expertise has been licensed in the state of Nevada for concentrates prepared from distillates of phytocannabinoids and packaged in vaporizer pen cartridges. The Company brings deep technical and brand expertise to extraction, formulation, development and marketing of cannabis distillate-based products.


Investor Relations Contact:
Kevin Keagan
Chief Executive Officer
Phone: 1 (647) 449 - 7352
Email: kkeagan@beleave.com


Forward-Looking Statements


This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52826

!
Thumb 8020 monitor 200200 2

8020 Admin

1 month ago

8020 Admin posted a press release Beleave Announces Consulting Agreement with Shaxon Enterprises in BELEAVE KANNABIS CORP.

Toronto, Ontario--(Newsfile Corp. - January 24, 2020) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has entered into a consulting agreement (the "Agreement") with Shaxon Enterprises Ltd. ("Shaxon" or the "Consultant"), with respect to Shaxon providing consulting services to the Company, effective February 1, 2020.


As part of the agreement, Don Shaxon, Chief Executive Officer of Shaxon Enterprises, will be a special advisor to the Company's Board of Directors and provide advice regarding Beleave's operations, business development, business opportunities, raising capital, management strategies, and corporate communications.


"The legal cannabis industry will forever be changing and evolving. While the industry is still in its infancy, these frequent regulation changes and market fluctuations present new opportunities that weren't previously available," said Shaxon. "With the Canadian rollout of Cannabis 2.0, Beleave has become one of very few licensed producers currently positioned to take full advantage of this budding market."


In addition, Shaxon Enterprises team members, Jason Springett, Corporate Development Manager, and Mike McMillan, Business Development and Strategic Alliance Manager will assist in the growth and development of an innovative future for Beleave.


"I am very excited to be a part of the Beleave team," said McMillan. "I'm equally excited to be able to work with a company that possesses such incredible potential."


About Beleave Inc.


Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives.


Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2020. Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.


Investor Relations Contact:
Kevin Keagan
Chief Executive Officer
Phone: 1 (647) 449 - 7352
Email: kkeagan@beleave.com


Forward-Looking Statements


This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.


"The approval of cannabis vape pens in Canada comes in the midst of news of lung ailments in the U.S. associated with vaping. Many of those who fell ill were vaping contaminated black-market cannabis oil. States typically don't require manufacturers to submit safety data before marketing their products, nor do they conduct random spot checking of cannabis products at production premises to make sure that what manufacturers claim about their products is true.



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/51797

!
Thumb 8020 monitor 200200 2

8020 Admin

3 months ago

8020 Admin posted a press release IIROC Trade Resumption - BE in BELEAVE KANNABIS CORP.





VANCOUVER, Dec. 19, 2019 /CNW/ - Trading resumes in:


Company: Beleave Inc.


CSE Symbol: BE


Resumption (ET): 10:00 AM


IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.


SOURCE Investment Industry Regulatory Organization of Canada (IIROC)


View original content: http://www.newswire.ca/en/releases/archive/December2019/19/c7651.html



For further information about IIROC's trading halt policy, please see Trading Halts & Timely Disclosure (http://www.iiroc.ca/industry/marketmonitoringanalysis/Pages/Trading-Halts-Timely-Disclosure.aspx) at www.iiroc.ca under the Halts & Resumptions tab. Please note that IIROC staff cannot provide any information about a specific halt beyond what is contained in this halt notice. For general information about IIROC, contact IIROC's Complaints & Inquiries team at inquiries@iiroc.ca or 1-877-442-4322 (Option 2). For company-related enquiries, contact the company directly.

!
Thumb 8020 monitor 200200 2

8020 Admin

3 months ago

8020 Admin posted a press release Beleave Receives Purchase Order for Cannabis 2.0 Products and Provides Other Operational Updates in BELEAVE KANNABIS CORP.

Announcing new product line, Compliance Brand, to join Flyte Classic vape pens in Cannabis 2.0 product line, The Company has $2.7 Million in orders for Cannabis 2.0 products, which will ship in early 2020

Toronto, Ontario--(Newsfile Corp. - December 19, 2019) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") is pleased to provide the following updates on its operations.


Compliance Brand Topicals


Beleave is excited to announce the launch of Compliance Brand, a new line of recreational cannabis-infused topical products, and the second initiative from Beleave and Volero Brands Inc.'s ("Volero") joint venture (the "Joint Venture" or "Partnership") after Flyte Classic vape pens. Announced on October 2019, the Partnership was formed to develop, produce, and distribute cannabis extracts, topicals, and edibles for the Canadian adult-use market.


Compliance Brands will launch with three products:



  • THC-Infused Face Serum

    • An exceptionally light oil-based face serum that absorbs almost instantly into skin. This oil blend, high in linoleic acids, will not leave a greasy feeling on your skin. Contains jojoba seed, rosehip and lavender oils with a hemp seed ester and vitamin E.





  • THC-Infused Bath Oil

    • All you need is a gentle stir to mix this product into your bath right away without slicks or residues. Contains hemp seed, birch bark, eucalyptus, marjoram, black pepper and nutmeg oils.





  • THC-Infused Multi-Use Balm

    • This multi-purpose balm was created for every skin. Can be applied to lips, elbows, knees, heels or anywhere else that needs help and hydration. Contains coconut, apricot, hemp seed, jojoba, peppermint, rosemary and lavender oils with vitamin E.




Purchase Orders and Cannabis 2.0 Sales

This week, Beleave received the largest purchase order from a province in the Company’s history. The Company now has $2.7 Million in orders, which will ship in early 2020, for Cannabis 2.0 products.


Additional Employment Positions


Beleave's Human Resources team is seeking applications for seven new employment positions within the Company to bolster its workforce to assist with expanded operations in the coming months. Available positions will be posted publicly as needed.


Lloydminster, Saskatchewan Retail Store Update


As previously announced, the Company has finalized the sale of its retail location in Lloydminster, Saskatchewan and met all the criteria for the transfer of the license to the purchaser. The Company is now awaiting the SLGA's transfer of the license for the transaction to be completed, which it expects in the very near future.


London, Ontario Facility Update


With 250,000 sq ft of greenhouse space and 85 acres of land, the London, Ontario facility has received tremendous interest since it was placed on the market earlier this year. The Company looks forward to providing additional updates once an agreement has been finalized.


ABOUT BELEAVE INC.


Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives.


Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2019. Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.

Investor Relations Contact:
Kevin Keagan
Chief Executive Officer
Phone: 1 (647) 449 - 7352
Email: kkeagan@beleave.com

Forward-Looking Statements


This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.


To view the source version of this press release, please visit https://www.newsfilecorp.com/release/50951

!
Thumb 8020 monitor 200200 2

8020 Admin

3 months ago

8020 Admin posted a press release Beleave Provides Update on Company Leadership in BELEAVE KANNABIS CORP.

Toronto, Ontario--(Newsfile Corp. - December 19, 2019) - Today, Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") announces the appointment of Mr. Kevin Keagan as its Chief Executive Officer, effective immediately, replacing Ms. Jeannette VanderMarel, who has resigned from her position. Ms. VanderMarel will maintain her position on the Company's board.


Mr. Keagan joined Beleave in October 28, 2018 as the Company's Chief Communications Officer. He brought his extensive experience, with over 25 years in capital markets working within the financial services industry, to his oversight of the operation, expansion, and direction of Beleave's communications and capital markets initiatives.


In January 2019, Kevin became Beleave's interim Chief Financial Officer, a role he performed until his appointment as CEO today.


"This has been a demanding year for the cannabis industry, and I appreciate the hard work, innovation, and determination that is required as we move steadfastly into the future," said Keagan. "I look forward to continuing to realize the benefits of our efforts, announcing new products and strategies, and evolving to grow our business in this exciting time. Canadians are increasingly looking for new and safe ways to consume cannabis, and our investments in Cannabis 2.0 products allows us to meet that demand, while maintaining strict protocols and introducing higher-margin, standardized products - strengthening our bottom line."


Beleave also announced that Debora Bielecki has voluntarily resigned from her position on Beleave's Board of Directors, effective immediately.


ABOUT BELEAVE INC.


Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives.


Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2019. Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.

Investor Relations Contact:
Kevin Keagan
Chief Executive Officer
Phone: 1(647)449-7352
Email: kkeagan@beleave.com


Forward-Looking Statements


This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/50948

!
Thumb 8020 monitor 200200 2

8020 Admin

3 months ago

8020 Admin posted a press release IIROC Trading Halt - BE in BELEAVE KANNABIS CORP.





VANCOUVER, Dec. 18, 2019 /CNW/ - The following issues have been halted by IIROC:


Company: Beleave Inc.


CSE Symbol: BE


Reason: At the request of the Company Pending News


Halt Time (ET): 10:32 AM


IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.


SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions


View original content: http://www.newswire.ca/en/releases/archive/December2019/18/c8499.html

For further information about IIROC's trading halt policy, please see Trading Halts & Timely Disclosure (http://www.iiroc.ca/industry/marketmonitoringanalysis/Pages/Trading-Halts-Timely-Disclosure.aspx) at www.iiroc.ca under the Halts & Resumptions tab. Please note that IIROC staff cannot provide any information about a specific halt beyond what is contained in this halt notice. For general information about IIROC, contact IIROC's Complaints & Inquiries team at inquiries@iiroc.ca or 1-877-442-4322 (Option 2). For company-related enquiries, contact the company directly.

!
Thumb 8020 monitor 200200 2

8020 Admin

4 months ago

8020 Admin posted a press release Beleave Announces Joint Venture with Volero Brands to Launch Cannabis 2.0 Products in Canada in BELEAVE KANNABIS CORP.

Toronto, Ontario--(Newsfile Corp. - October 31, 2019) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") and Volero Brands Inc. ("Volero") are pleased to announce that they have entered into a definitive agreement (the "Joint Venture Agreement") to form a joint venture (the "Joint Venture" or "Partnership") to develop, produce, and distribute cannabis extracts, topicals and edibles for the Canadian market.


"Innovation, strong leadership, and the ability to navigate the regulatory landscape are core capabilities required for differentiation and future success in the rapidly evolving Canadian cannabis market," said Jeannette VanderMarel, Beleave CEO. "We are thrilled to be working with Sean and the Volero team as they have an unparalleled depth of knowledge and experience in the cannabis space. Our partnership with Volero will allow us to effectively produce the quality products clients and patients have come to expect from Beleave."


"We're excited to partner with Beleave and bring an entirely new product category to the Canadian market. Our team knows that the best results are delivered when great people come together to collaborate with a common vision. This is exactly the environment we have right now with the team at Beleave," said Sean Trustham, Volero CEO. "This is just the beginning. As we continue to develop and introduce unique products in the coming months, we will keep setting ourselves and our brands apart to ensure that, in the end, we will have fully leveraged this opportunity to establish a leading position in the cannabis extracts markets."


Canadians are increasingly looking for new and safe ways to consume cannabis, and this partnership allows Beleave to meet that need while maintaining strict protocols and introducing standardized products with higher margins. Cannabis 2.0 regulations are in response to a significant and unmet demand in the legal medical cannabis market to provide more flexibility in how cannabis is consumed.


Leveraging Beleave's production capacity, scale, reach, and sales network to drive growth for new products in the Canadian market, the Partnership outlines plans for the roll-out of extracts, topicals and edibles throughout 2020, beginning with Flyte vape pens in December 2019. Launching with six flavours, Flyte pens and refill cartridges are the first of a broader line of cannabinoid-based products Beleave and Volero intend to launch in the future.


"The cannabis concentrate that will be sold in Flyte vapes will meet federal quality regulations as outlined by Health Canada," said Dr. Roger Ferreira, Beleave's Chief Science Officer. "When you extract and concentrate cannabis, you're able to deliver the active ingredient as a more potent formulation. We start with cannabis that is rigorously tested and free from pesticides and heavy metals to ensure a clean and safe end product. We work hard to produce high quality, standardized products to meet the demands of our clients and patients, with safety top of mind."


The first release of Flyte vape pen cartridges will be sold in 0.5 gram net weight units (kits include slim-form 100mAh batteries). Each cartridge will contain 300 mg of THC. Like all Beleave products, Flyte pens will come with publicly available, independent laboratory analysis reports on cannabinoid potency, terpene profiles, as well as pesticide and contaminant screening.


On October 30, Beleave announced it had received an amendment to its processing license from Health Canada to authorize the sale of cannabis extracts, topicals and edible cannabis products to provincially and territorially authorized retailers. The amendment allows Beleave to participate in the newly announced Cannabis 2.0 regulations that went into effect October 17, 2019. Companies must give notice to Health Canada about new products and Beleave has already submitted the required 60-day notification, with sales anticipated to begin this December through Beleave's existing sales and distribution channels.


About Volero Brands


Volero Brands is a privately held, British Columbia-based company engaged in the development of a family of cannabis brands and delivery systems for Canadian and international markets. The Company's flagship brand is Flyte, a suite of top-quality cannabis distillate products. The Flyte brand and expertise has been licensed in the state of Nevada for concentrates prepared from distillates of phytocannabinoids and packaged in vaporizer pen cartridges. The Company brings deep technical and brand expertise to extraction, formulation, development and marketing of cannabis distillate-based products.


About Beleave Inc.


Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives.


Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2019. Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.


Investor Relations Contact:


Kevin Keagan
Interim Chief Financial Officer
Phone: 1 (647) 449 - 7352
Email: kkeagan@beleave.com


Forward-Looking Statements


This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/49299

!